Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000862319 | SCV001002808 | benign | not provided | 2023-12-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000862319 | SCV004165768 | likely benign | not provided | 2023-07-01 | criteria provided, single submitter | clinical testing | TAF1: BP4, BP7, BS2 |
Diagnostic Laboratory, |
RCV000862319 | SCV001743335 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000862319 | SCV001974293 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004753058 | SCV005359798 | likely benign | TAF1-related disorder | 2024-03-07 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |